Clinical Trials Browser

Phase 1/2 × INDUSTRY × Infectious Mononucleosis × Clear all

NCT05164094 2025-05-15

A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1189, in 10- to 30-Year-Old Healthy Adolescents and Adults

Phase 1/2 Active not recruiting

Infectious Mononucleosis, Epstein-Barr Virus Infections